IMBRUVICA® CLL/SLL Cost
Coverage and Cost
When you have support, such as help understanding your insurance coverage and potential ways to pay for IMBRUVICA®, you may feel more confident during treatment. The YOU&i™ Support Program is here to help answer some of your questions about the financial aspects of taking IMBRUVICA®.
Learn more about your insurance coverage and potential financial support options.
Call the YOU&i™ Support Program
1-877-877-3536 | Menu Option 1
Monday-Friday, 8:00am-8:00pm and Saturday, 8:00am-5:00pm ET
IMBRUVICA® Copay Program
If you have commercial insurance, you could get IMBRUVICA® for as little as
$10
per prescription*
*Eligible patients may qualify to pay $10 per prescription of IMBRUVICA® until the maximum limit of $24,600 per calendar year is reached. The IMBRUVICA® Copay Program cannot be used with any other federally-funded prescription insurance plan. Federally-funded plans include Medicare Part D, Medicare Advantage Plan, Medicaid, TRICARE, or any other federal or state healthcare plan, including pharmaceutical assistance programs.
Wholesale Acquisition Cost (WAC)
The Wholesale Acquisition Cost (WAC), also known as the list price, 30-day supply of IMBRUVICA® is $13,892.25† as of January 2020. A majority of patients do not pay full list price once insurance coverage is applied.
†The list price for a 30-day supply of IMBRUVICA® (ibrutinib) 420-mg tablets, which is the recommended dose for CLL.
Understanding Insurance for CLL Patients‡
| If you have: | You could pay: |
| Commercial Insurance (usually provided by an employer) | As little as $10 per month* with the IMBRUVICA® Copay Program. Learn More and Enroll Here |
| Medicare (Part D and LIS) |
Most patients with Medicare pay between $0 and $53 per month for IMBRUVICA® in CLL.‖ This number represents Medicare Part D, including those with LIS. Actual out-of-pocket costs may vary based on dosing, indication, site of care, insurance coverage, and your eligibility for support programs (some of which require you to apply for the support, like independent charitable foundations). The information below is based on the benefit structure for Medicare Part D and LIS. Please see Medicare.gov for more information. Medicare Part D Most Medicare patients have standard Part D prescription coverage, which has different costs depending on deductibles and coverage gaps. With standard Part D prescription coverage, you could pay $695 - $2,881 per month, depending on coverage phase. Monthly out-of-pocket costs for IMBRUVICA® may vary depending on coverage phase and other medications you may be taking. Medicare Low Income Subsidy Eligible patients may be able to access Brand name drugs for less than $10 per month. You may be eligible for the Extra Help program provided by the Social Security Administration. We can help you understand what these costs mean to you by calling 1-877-877-3536 (Menu Option 1). |
| Medicaid, including Fee-for-Service and Managed | The information below is based on the benefit structure for Medicaid. Please see Medicaid.gov for more information.
$8.00 or less per month, depending on state plan. |
| Other Insurance (VA, DOD, Tricare, others) | Because coverage varies by plan, call 1-877-877-3536 (Menu Option 1) to find out how much IMBRUVICA® will cost for you. |
| Uninsured or if you cannot afford your medication | Pharmacyclics and Janssen are committed to helping the uninsured gain access to our medicine. Call 1-877-877-3536 (Menu Option 1) or visit www.pparx.org for assistance. |
‡Important Details About Understanding Your Individual Costs:
Your type of health or prescription insurance plan will determine exactly how much you will pay. The benefit structure is based on the publicly available information for Medicare Part D, LIS, and Medicaid and cost is accurate as of January 2020 for a 30-day supply of IMBRUVICA® (420-mg dose).
*Eligible patients may qualify to pay $10 per prescription of IMBRUVICA® until the maximum limit of $24,600 per calendar year is reached. The IMBRUVICA® Copay Program cannot be used with any other federally-funded prescription insurance plan. Federally-funded plans include Medicare Part D, Medicare Advantage Plan, Medicaid, TRICARE, or any other federal or state healthcare plan, including pharmaceutical assistance programs.
‖Approximately 75% of US patients in this category pay an amount in this range. Actual out-of-pocket costs may vary based on dosing, indication, site of care, insurance coverage, and your eligibility for support programs (some of which require you to apply for the support, like independent charitable foundations). Contact your insurance provider for more details on your individual plan. Out-of-pocket cost estimates are based on approved pharmacy claims, normalized to a 30-days’ supply, after application of insurance benefits. Costs do not include medical claims and starter kits. Note: This is based on information licensed from IQVIA™: IQVIA™ Out of Pocket Cost (OPC Tool) for the period September 2019 – August 2020, reflecting estimates of real-world activity. All rights reserved.
No matter what type of insurance plan you have, or if you don't have insurance, the YOU&i™ Support Program can help you understand your coverage and potential financial support options for IMBRUVICA®.
1-877-877-3536 | Menu Option 1
Monday-Friday, 8:00 am-8:00 pm and Saturday, 8:00am-5:00pm ET
Other resources
Johnson & Johnson Patient Assistance Foundation, Inc.
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, nonprofit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies. To see if you might qualify for assistance, please contact a JJPAF program specialist at 800-652-6227 (Monday – Friday, 9:00 AM to 6:00 PM ET) or visit the foundation website at JJPAF.org.
